❌

Reading view

F.D.A. Seeks More Oversight of Vaccine Trials and Approvals

The agency’s top vaccine regulator proposed broad changes, claiming that a new review linked 10 children’s deaths to the Covid vaccine. But public health experts questioned the findings, wanting to examine the data.

Β© Hannah Beier for The New York Times

Dr. Vinay Prasad, the F.D.A.’s top vaccine official, suggested in a memo that the deaths were related to vaccine-related myocarditis but did not offer data to support his conclusions.
  •  

U.S. Announces Negotiated Prices for 15 Drugs Under Medicare

The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which would have reduced its spending on those drugs by 44 percent.

Β© Helen Sessions/Alamy

The 15 drugs include widely used inhalers, such as Breo Ellipta, and treatments for cancer, diabetes and depression.
  •  

Cassidy Got Pledges From RFK Jr. on Vaccines. They Haven’t Stuck.

Before casting a crucial vote for the health secretary, the top Senate Republican laid out several specific commitments he had secured, some of which appear to have been breached.

Β© Haiyun Jiang for The New York Times

Senator Bill Cassidy during a committee hearing on Robert F. Kennedy Jr.’s nomination to be health secretary in February.
  •  

RFK Jr. Says He Instructed CDC to Change Vaccines and Autism Language on Website

In an interview, Health Secretary Robert F. Kennedy Jr. cited gaps in vaccine safety research. His critics say he is ignoring a larger point: Vaccines save lives.

Β© Tierney L. Cross/The New York Times

It is highly unusual for a health secretary to personally order a change to scientific guidance, but Robert F. Kennedy Jr. ordered the language adjustment on the C.D.C. website.
  •  

RFK Jr. Walks a Tightrope on Trump Deal for Obesity Drugs

The weight loss medicines are proving to be a test case for Robert F. Kennedy Jr., the health secretary, in straddling divisions between his supporters and the president.

Β© Doug Mills/The New York Times

Robert F. Kennedy Jr., the health secretary, appearing in the Oval Office on Nov. 6 with other health officials, the chief executives of Novo Nordisk and Eli Lilly and others.
  •  

With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm

The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.

Β© Justin Sullivan/Getty Images

Kimberly-Clark is gambling that it can outlast the Trump administration’s Tylenol-autism warnings. Kenvue has a broader portfolio of brand-name products like Band-Aid and Neutrogena.
  •